Antithrombotic treatment after stroke due to intracerebral haemorrhage

Author:

Cochrane Alexia1,Chen Chen234,Stephen Jacqueline5,Rønning Ole Morten6,Anderson Craig S78,Hankey Graeme J910,Al-Shahi Salman Rustam11

Affiliation:

1. Medical School; The University of Edinburgh; Edinburgh UK

2. The George Institute for Global Health, Faculty of Medicine, UNSW; Sydney Australia

3. The George Institute for Global Health; Beijing China

4. Department of Neurology; Shanghai East Hospital, School of Medicine, Tongji University; Shanghai China

5. Edinburgh Clinical Trials Unit, Usher Institute; The University of Edinburgh; Edinburgh UK

6. Department of Neurology; Akershus University Hospital; Lørenskog Norway

7. The George Institute for Global Health, Faculty of Medicine; University of New South Wales; Sydney Australia

8. The George Institute China at Peking University Health Science Center; Beijing China

9. Medical School, Faculty of Health and Medical Sciences; The University of Western Australia; Perth Australia

10. Perron Institute for Neurological and Translational Science; Perth Australia

11. Centre for Clinical Brain Sciences; The University of Edinburgh; Edinburgh UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference71 articles.

1. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial;Schreuder;Lancet Neurology,2021

2. Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation (APACHE-AF): study protocol for a randomised controlled trial;Van Nieuwenhuizen;Trials,2015

3. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral haemorrhage;Dickmann;Klinische Wochenschrift,1988

4. Shoamanesh A Sharma M Dowlatshahi D Pikula A Smith EE Gladstone DJ Non-vitamin K oral anticoagulants in intracerebral hemorrhage survivors with atrial fibrillation: primary results of the NASPAF-ICH randomized trial International Stroke Conference, Session A28 - Late-Breaking Science Oral Abstracts II Los Angeles 2020

5. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage;Orken;Neurologist,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3